Medicine
- Xagena
Medicine
News
Drugs
Xapedia
Farmaci
Farmacia
Medicina
Specialità
Allergologia
Andrologia
Angiologia
Aritmologia
Biomedicina
Cardiologia
Chirurgia
Dermatologia
Diabetologia
Diagnostica
Ematologia
Endocrinologia
Epatologia
Erboristeria
Farmacologia
Gastroenterologia
Ginecologia
Infettivologia
Metabolismo
Nefrologia
Neurologia
Obesiologia
Oftalmologia
OncoGinecologia
Oncologia
Ortopedia
Otorinolaringoiatria
Pneumologia
Psichiatria
Reumatologia
Tiroidologia
UroGinecologia
Urologia
Virologia
Low-dose Aspirin for prevention of stroke in women
Depo-subQ Provera 104 ( Medroxyprogesterone ) for endometriosis pain
Intracranial stenosis, Aspirin is safer than Warfarin for stroke prevention
Chronic hepatitis B, FDA approves Entecavir
Viagra may cause ischemic optic neuropathy
Lung cancer, positive preliminary data for ProMune
Folate intake associated with hypertension in women
Bortezomib approved for second-line multiple myeloma
Abbott, ADHD drug is being discontinued
Osteoporosis, FDA approves once-monthly Ibandronate
Finasteride may prevent prostate cancer
Obstructive sleep apnea and risk of sudden death from cardiac causes
Coronary heart disease, high-versus low dose Atorvastatin
Public Citizen petitions FDA to withdraw Abbott’s Cylert
Epilepsy drug Valproate during pregnancy may increase the risk of severe birth defects
Nesiritide increases the risk of worsening renal function in patients with ADHF
Avonex associated with cases of severe liver damage
New warning for Xigris, a sepsis drug
Role of anti-hepatitis C virus treatment in patients with B-cell non-Hodgkin's lymphoma and HCV infection
Cholesterol affects tumor survival
Smoking may be a risk factor for progression of multiple sclerosis
BNP is a strong prognostic indicator in patients with heart failure
FDA approves Symlin, new diabetes drug
Parecoxib and Valdecoxib, increased cardiovascular events after CABG
Aliskiren, a novel renin inhibitor in hypertension
FDA approves Temodar as treatment for glioblastoma multiforme
Vitamin E can increase the risk for heart failure
Lung cancer, Avastin extends survival
Autoantibody formation in patients with rheumatoid arthritis treated with Infliximab
Rasagiline as an adjunct to Levodopa in patients with Parkinson's disease and motor fluctuations
Risk factors for preeclampsia
Aripiprazole for maintaining efficacy in bipolar I disorder
Two atopic dermatitis drugs should be used cautiously
Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin’s lymphoma
Bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma
Non-diabetic proteinuric nephropathies, add-on therapy provides no benefit
Addition of Clopidogrel to Aspirin and fibrinolytic therapy proves beneficial for myocardial infarction
Celecoxib inhibits prostate cancer growth
ADRAC : bisphosphonates and osteonecrosis of the jaw
APC study, cardiovascular risk associated with Celecoxib
Efficacy of Lenalidomide in relapsed or refractory multiple myeloma
WHO: public health concern on acrylamide in food
Genetic variants in UBQLN1 increase the risk of Alzheimer’s disease
Diabetes increases liver cancer risk
Alzheimer’s disease could be a neuroendocrine disorder
FDA has approved Pegasys and Copegus for the treatment of chronic hepatitis C in HIV patients
Thalidomide attenuates weight loss and wasting in pancreatic cancer
European Union, Pegasys approved for the treatment of chronic hepatitis B
Low-dose Aspirin prevents strokes in women
Peginterferon alfa-2a plus Ribavirin for chronic hepatitis C virus infection in HIV-infected patients
Drug-eluting stent: Cypher and Taxus, comparable efficacy in preventing in-segment binary restenosis
Recombinant activated factor VII in acute intracerebral haemorrhage
FDA has approved Candesartan Cilexetil for the treatment of heart failure
Treatment of systolic hypertension in older patients with SBP of at least 160 mm Hg is supported by strong evidence
A to Z Trial , Z phase : Simvastatin did not achieve the prespecified end point
ACTION trial : addition of Nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival
Alzheimer’s drugs, NICE proposes to withdraw from NHS
Therapeutic vaccine shows promise in men with prostate cancer
Prostate cancer, vitamin E could cut the risk
Dietary fiber intake reduces blood pressure in patients with hypertension
FDA: Crestor, favorable risk/benefit ratio
Use of Cannabis may lead to psychotic symptoms
Folate and vitamin B12 can reduce the risk of hip fracture in elderly patients following a stroke
Multiple Sclerosis, Tysabri withdrawn from market
Guidelines on use of Antiretroviral Drugs to prevent HIV infection after sexual, drug use, and accidental exposure
Linezolid and neuropathy
Reports of lymphoma and skin cancer in patients treated with Elidel cream
EMEA, regulatory actions for the COX-2 inhibitor
New Warning on Depo-Provera Contraceptive Injection
NCI has stopped a clinical trial of the Cox-2 Inhibitor Celebrex
Bextra, boxed warning concerning severe skin reactions and warning regarding cardiovascular risk
Warning on lymphoma risk with TNF blockers
Treatment for patients with the metabolic syndrome
Vioxx, increased risk of heart attack and stroke
Potential adverse effects of SSRIs and other anti-depressants on newborns
Valdecoxib, severe cutaneous reactions
Pagine successive
«
21
22
23
24
25
26
27
28
[
29
]
Web
Xagena News
Link
Specialità
Patologie
Patologie
Acne
Aids
Allergie
Alzheimer
Angina
Ansia
Aritmie
Artrite
Asma
Bronchite
Calvizie
Cefalea
Cistite
Crohn
Depressione
Diabete
Disturbo Bipolare
Dolore
Epatite
Epilessia
Gastrite
Glaucoma
Herpes
Ictus
Impotenza
Infarto
Infezioni
Insonnia
Ipertensione
Ipertrofia Prostatica
Malattie Rare
Micosi
Osteoporosi
Parkinson
Pediatria
Psoriasi
Schizofrenia
Sclerosi Multipla
Scompenso Cardiaco
Trombosi
Tumori
Ulcere
Medilearn
Cardiologia
News
Farmaci
Molecolare
Invasiva
Cuore
Farmaci
News
Farmacovigilanza
Farmacia
News
Fitoterapia
Ginecologia
News
Farmaci
Contraccezione
Gravidanza
Medicina
News
Farmaci
Neurologia
News
Farmaci
Oncologia
News
Farmaci
Ospedali
News
Pronto Soccorso
News
Farmaci
Salute
News
Farmaci
Vaccini
News
Vaccinazioni
Xagena Medicina
News
Medicine
News
Drugs
© XAGENA 2010 - P.IVA: 04454930969 - REA: 1748680 - Tutti i diritti riservati